Treatment of Acute Hepatic Encephalopathy: Comparing the Effects of Adding Rifaximin to Lactulose on Patient Outcomes
Conclusion:
Addition of rifaximin to lactulose for treatment of acute HE did not reduce hospital LOS; however, it did result in lower readmission rates for HE at 180 days.
Source: Journal of Pharmacy Practice - Category: Drugs & Pharmacology Authors: Courson, A., Jones, G. M., Twilla, J. D. Tags: Research Articles Source Type: research
More News: Cirrhosis | Drugs & Pharmacology | Liver | Liver Disease | Study | Urology & Nephrology | Xifaxan